Jim McDermott has been appointed managing director of Quintiles’ Market Intelligence Practice for the Consulting group. The group provides analytic tools and methodologies that combine techniques, decision modeling and analytics, to help guide biopharmaceutical companies through strategic planning.

“We are excited to have Jim join Consulting to lead this insight-driven team,”said Jay Norman, president of Quintiles Consulting. “Our consultants bring fresh thinking on market intelligence to help biopharma companies make better decisions throughout the entire product lifecycle. Developing a market-leading, profitable business strategy requires relevant, robust market intelligence – and consulting delivers.”

Mr. McDermott has more than 30 years of biopharma industry experience. For the past 10 years, he worked at Decision Resources, Inc., most recently as global practice leader of their consultancy group, where he was responsible for helping build the company’s applied syndicated data business for leading biopharmaceutical companies. Prior to DRI, he held positions at Index, SRI International, Nervewire and Procter & Gamble.